Mastodawn

Timothy Menz, MD Mar 17, 2023

Court Cantrell does not comply Mar 15, 2023

"Read the books they're banning. That's where the good stuff is."

--LeVar Burton

Timothy Menz, MD Mar 17, 2023

Happy match day to all my wonderful docs out there! No matter where you end up, you’ve worked incredibly hard missing birthdays, weddings, and other life events all during a global pandemic. You are amazing. #Match2023

Timothy Menz, MD Jan 31, 2023

More evidence that #COVID19 is not benign in children and it’s in our best interest as parents and medical professionals to limit the transmission as much as we can.

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2800816

COVID-19 as the Underlying Cause of Death Among Individuals Aged 0 to 19 Years in the US

This cross-sectional study evaluates whether COVID-19 is among the top 10 causes of death in children and young people aged 0 to 19 years in the US.

Timothy Menz, MD Jan 6, 2023

Challenge accepted. #covid19 #zeroCovid #ventilationiskey #MaskUp #vaccinessavelives

https://www.usatoday.com/story/news/health/2023/01/06/covid-update-xbb-variant-symptoms-reinfection/10995204002/

People who haven't had COVID will likely catch XBB.1.5 – and many will get reinfected, experts say

New COVID variant XBB.1.5 is very contagious, meaning everyone is at risk for infection even if you've already had COVID. Here's what that means.

USA TODAY

Timothy Menz, MD Dec 29, 2022

Irene Tosetti, MD, MBA MPH Dec 29, 2022

RT @[email protected]

VV116 was developed in China 🇨🇳. However, it is NOT yet approved or marketed anywhere (except in Uzbekistan 🇺🇿).
As a result, VV116 won't have a major impact on the on-going tsunami of cases in China. https://twitter.com/NEJM/status/1608223774004097024

🐦🔗: https://twitter.com/julienpotet/status/1608378830133100544

NEJM on Twitter

“In a Chinese trial involving participants with symptomatic mild-to-moderate Covid-19, VV116 (an oral analogue of remdesivir) was noninferior to nirmatrelvir–ritonavir with respect to the time to sustained clinical recovery. Read the full study: https://t.co/zckTB3Rvb9”

Twitter

Timothy Menz, MD Dec 23, 2022

Andrew Lover Dec 23, 2022

MA state #COVID19 wastewater sampling

@COVIDPoops19 #COVID

🚀 Up up up, most everywhere.

(no data from Franklin; several others look stable)

Timothy Menz, MD Dec 13, 2022

https://chng.it/wLYp4RGtgT

Can you spare a minute to help this campaign?

Remove Twitter from Apple App Store and Google Play

Change.org

Timothy Menz, MD Dec 13, 2022

LaughterInLight Dec 13, 2022

Here is a petition regarding data safety and hate speech promoted on twitter:

https://chng.it/PWBTjdkchq

Can you spare a minute to help this campaign?

Remove Twitter from Apple App Store and Google Play

Change.org

Timothy Menz, MD Dec 6, 2022

Gregg Gonsalves Dec 6, 2022

"In March 2020, as the #Covid 19 pandemic swept across the United States, the nation’s pediatric providers and #pediatric units immediately pitched in to treat adults sickened by this then-mysterious and deadly disease. But now that the pediatric community is facing its own March 2020 with the confluence of Covid-19, #influenza, and respiratory syncytial virus (#RSV), the response from outside this community has been slow."

https://www.statnews.com/2022/12/06/covid-influenza-rsv-pediatricians-parents/?utm_source=STAT+Newsletters&utm_campaign=d51f6b89a1-MR_COPY_01&utm_medium=email&utm_term=0_8cab1d7961-d51f6b89a1-150848481

Pediatricians and parents on the brink: This is their March 2020

The slow response to the the confluence of Covid-19, influenza, and respiratory syncytial virus among children speaks volumes about how the U.S. prioritizes — or more accurately doesn't prioritize — the health of children.

STAT

Timothy Menz, MD Dec 6, 2022

#Pfizer submits application for EUA for #covid19 #bivalent #vaccine #booster for children under 5: https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-submit-application-us-fda-emergency-1